PLAIR welcomes bioMérieux as a Strategic Investor Reinforcing Global Adoption of RAPID-C+
PLAIR, the Swiss scale-up advancing pharmaceutical environmental monitoring, is proud to announce a strategic investment from bioMérieux, a global leader in the field of in vitro diagnostics.
Read More